The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis

Joanna L. Sylman, Annachiara Mitrugno, Michelle Atallah, Garth W. Tormoen, Joseph J. Shatzel, Samuel Tassi Yunga, Todd H. Wagner, John T. Leppert, Parag Mallick, Owen J.T. McCarty

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

In this review, we discuss the interaction between cancer and markers of inflammation (such as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of routinely monitoring these markers in peripheral blood measurement assays. Next, we discuss the prognostic value and limitations of using inflammatory markers such as neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and C-reactive protein measurements. Furthermore, the review discusses the benefits of combining multiple types of measurements and longitudinal tracking to improve staging and prognosis prediction of patients with cancer, and the ability of novel in silico frameworks to leverage this high-dimensional data.

Original languageEnglish (US)
Article number78
JournalFrontiers in Oncology
Volume8
Issue numberMAR
DOIs
StatePublished - Mar 21 2018

Keywords

  • Biomarkers
  • C-reactive protein
  • Cancer
  • Longitudinal
  • Neutrophil-to-lymphocyte
  • Platelet-to-lymphocyte
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis'. Together they form a unique fingerprint.

Cite this